Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1775-1790
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1775
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1775
Table 1 Description of included traits
Group | Trait | ID | Sample size | Year | Case/control | SNPs |
Exposures | T2D | ebi-a-GCST90093109 | 50533 | 2022 | 16677/33856 | 13403040 |
Hyperlipidemia | ebi-a-GCST90090994 | 9714 | 2022 | 3310/6404 | 592502 | |
Hypertension | ebi-a-GCST90038604 | 484598 | 2021 | 129909/354689 | 9587836 | |
Outcomes | CHB | ebi-a-GCST90018804 | 351885 | 2021 | 145/351740 | 19079722 |
CHC | ebi-a-GCST90018805 | 352013 | 2021 | 273/351740 | 19074546 |
- Citation: Liang LB, Liu XP, Mao TR, Su QL. Metabolic disorders and hepatitis: Insights from a Mendelian randomization study. World J Gastrointest Surg 2024; 16(6): 1775-1790
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1775.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1775